Avoiding the unavoidable, SGLT2 inhibitor in secondary prevention of CVD

Rp25.000

Pembicara : dr. Ade Meidian Ambari, SpJP(K)

Category:

Reviews

There are no reviews yet.

Be the first to review “Avoiding the unavoidable, SGLT2 inhibitor in secondary prevention of CVD”

Your email address will not be published. Required fields are marked *

🚨 Mark Your Calendar! 🚨
13th Bandung Cardiovascular Update x 8th INAPREVENT

🗓 May 8th-11th, 2025

Make the most of your long weekend by joining us in Bandung! Get ready for a meaningful and inspiring scientific experience.

Click Here 

See you soon !